Richard E. Chaisson - Publications

Affiliations: 
Johns Hopkins University, Baltimore, MD 
Area:
Epidemiology, Public Health

276 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Chaisson LH, Saraceni V, Cohn S, Seabrook D, Cavalcante S, Chaisson RE, Golub J, Durovni B. CD4 count stratification to guide tuberculosis preventive therapy for people living with HIV. Aids (London, England). PMID 31634189 DOI: 10.1097/QAD.0000000000002398  0.36
2019 Salazar-Austin N, Cohn S, Lala S, Waja Z, Dooley KE, Hoffmann CJ, Chaisson RE, Martinson N. Isoniazid Preventive Therapy and Pregnancy Outcomes In HIV-Infected Women in the Tshepiso Cohort. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 31631221 DOI: 10.1093/cid/ciz1024  0.48
2019 Kendall EA, Durovni B, Martinson NA, Cavalacante S, Masonoke K, Saraceni V, Lebina L, Efron A, Cohn S, Chon S, Chaisson RE, Dowdy DW, Golub JE. Adherence to tuberculosis preventive therapy measured by urine metabolite testing among people with HIV. Aids (London, England). PMID 31567163 DOI: 10.1097/QAD.0000000000002380  0.36
2019 Salazar-Austin N, Dowdy DW, Chaisson RE, Golub JE. 70 years of TB Prevention: Efficacy, Effectiveness, Toxicity, Durability and Duration. American Journal of Epidemiology. PMID 31364692 DOI: 10.1093/aje/kwz172  0.36
2019 Salazar-Austin N, Cohn S, Barnes GL, Tladi M, Motlhaoleng K, Swanepoel C, Motala Z, Variava E, Martinson N, Chaisson RE. Improving TPT Uptake: A Cluster-Randomized Trial of Symptom-Based Versus Tuberculin Skin Test-Based Screening of Household Tuberculosis Contacts Less than 5 Years of Age. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 31127284 DOI: 10.1093/cid/ciz436  0.36
2019 Koor GW, Paximadis M, Picton ACP, Karatas F, Loubser SA, He W, Ahuja SK, Chaisson RE, Martinson N, Ebrahim O, Tiemessen CT. Cis-regulatory genetic variants in the CCR5 gene and natural HIV-1 control in black South Africans. Clinical Immunology (Orlando, Fla.). PMID 31100442 DOI: 10.1016/j.clim.2019.05.009  0.36
2018 Dorjee K, Topgyal S, Dorjee C, Tsundue T, Namdol T, Tsewang T, Nangsel T, Lhadon D, Choetso T, Dawa T, Phentok T, DeLuca AN, Tsering L, Phunkyi D, Sadutshang TD, ... ... Chaisson RE, et al. High Prevalence of Active and Latent Tuberculosis in Children and Adolescents in Tibetan Schools in India: The Zero TB Kids Initiative in Tibetan Refugee Children. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 30462191 DOI: 10.1093/cid/ciy987  0.4
2018 Ngwira LG, Corbett EL, Khundi M, Barnes GL, Nkhoma A, Murowa M, Cohn S, Moulton LH, Chaisson RE, Dowdy DW. Screening for tuberculosis with Xpert MTB/RIF versus fluorescent microscopy among adults newly diagnosed with HIV in rural Malawi: a cluster randomized trial (CHEPETSA). Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 30059995 DOI: 10.1093/cid/ciy590  0.36
2017 Salazar-Austin N, Hoffmann J, Cohn S, Mashabela F, Waja Z, Lala S, Hoffmann C, Dooley KE, Chaisson RE, Martinson N. Poor Obstetric and Infant Outcomes in HIV-Infected Pregnant Women with Tuberculosis in South Africa: The Tshepiso Study. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 29028970 DOI: 10.1093/cid/cix851  0.48
2017 Adu-Gyamfi CG, Snyman T, Hoffmann CJ, Martinson NA, Chaisson RE, George JA, Suchard MS. Plasma Indoleamine 2, 3-Dioxygenase, a Biomarker for Tuberculosis in Human Immunodeficiency Virus-Infected Patients. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 65: 1356-1358. PMID 29017244 DOI: 10.1093/cid/cix550  0.36
2017 Gupte AN, Wong ML, Msandiwa R, Barnes GL, Golub J, Chaisson RE, Hoffmann CJ, Martinson NA. Factors associated with pulmonary impairment in HIV-infected South African adults. Plos One. 12: e0184530. PMID 28902919 DOI: 10.1371/journal.pone.0184530  0.36
2017 McIlleron H, Denti P, Cohn S, Mashabela F, Hoffmann JD, Shembe S, Msandiwa R, Wiesner L, Velaphi S, Lala SG, Chaisson RE, Martinson N, Dooley KE. Prevention of TB using rifampicin plus isoniazid reduces nevirapine concentrations in HIV-exposed infants. The Journal of Antimicrobial Chemotherapy. PMID 28419277 DOI: 10.1093/jac/dkx112  0.48
2016 Conde MB, Mello FC, Duarte RS, Cavalcante SC, Rolla V, Dalcolmo M, Loredo C, Durovni B, Armstrong DT, Efron A, Barnes GL, Marzinke MA, Savic RM, Dooley KE, Cohn S, ... ... Chaisson RE, et al. A Phase 2 Randomized Trial of a Rifapentine plus Moxifloxacin-Based Regimen for Treatment of Pulmonary Tuberculosis. Plos One. 11: e0154778. PMID 27159505 DOI: 10.1371/journal.pone.0154778  0.84
2016 Sterling TR, Scott NA, Miro JM, Calvet G, La Rosa A, Infante R, Chen MP, Benator DA, Gordin F, Benson CA, Chaisson RE, Villarino ME. Three months of weekly rifapentine plus isoniazid for treatment of M. tuberculosis infection in HIV co-infected persons. Aids (London, England). PMID 26990624 DOI: 10.1097/QAD.0000000000001098  0.84
2016 Dierberg KL, Dorjee K, Salvo F, Cronin WA, Boddy J, Cirillo D, Sadutshang T, Chaisson RE. Improved Detection of Tuberculosis and Multidrug-Resistant Tuberculosis among Tibetan Refugees, India. Emerging Infectious Diseases. 22. PMID 26889728 DOI: 10.3201/eid2203.140732  0.84
2016 Lanoix JP, Chaisson RE, Nuermberger EL. Shortening Tuberculosis Treatment With Fluoroquinolones: Lost in Translation? Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 62: 484-90. PMID 26527614 DOI: 10.1093/cid/civ911  0.84
2015 Denti P, Martinson N, Cohn S, Mashabela F, Hoffmann J, Msandiwa R, Castel S, Wiesner L, Chaisson RE, McIlleron H, Dooley KE. Population pharmacokinetics of rifampicin in pregnant women with tuberculosis and HIV co-infection in Soweto, South Africa. Antimicrobial Agents and Chemotherapy. PMID 26643345 DOI: 10.1128/AAC.02051-15  0.48
2015 Rangaka MX, Cavalcante SC, Marais BJ, Thim S, Martinson NA, Swaminathan S, Chaisson RE. Controlling the seedbeds of tuberculosis: diagnosis and treatment of tuberculosis infection. Lancet (London, England). PMID 26515679 DOI: 10.1016/S0140-6736(15)00323-2  0.84
2015 Lala SG, Little KM, Tshabangu N, Moore DP, Msandiwa R, van der Watt M, Chaisson RE, Martinson NA. Integrated Source Case Investigation for Tuberculosis (TB) and HIV in the Caregivers and Household Contacts of Hospitalised Young Children Diagnosed with TB in South Africa: An Observational Study. Plos One. 10: e0137518. PMID 26378909 DOI: 10.1371/journal.pone.0137518  0.84
2015 Hoffmann CJ, Cohn S, Mashabela F, Hoffmann JD, McIlleron H, Denti P, Haas D, Dooley KE, Martinson NA, Chaisson RE. Treatment failure, drug resistance, and CD4 T-cell count decline among postpartum women on antiretroviral therapy in South Africa. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 26334739 DOI: 10.1097/QAI.0000000000000811  0.84
2015 Martinson NA, Gupte N, Msandiwa R, Moulton LH, Barnes GL, Ram M, Gray G, Hoffmann C, Chaisson RE. Correction: CD4 and Viral Load Dynamics in Antiretroviral-Naïve HIV-Infected Adults from Soweto, South Africa: A Prospective Cohort. Plos One. 10: e0130509. PMID 26061975 DOI: 10.1371/journal.pone.0130509  0.84
2015 Zwerling AA, Sahu M, Ngwira LG, Khundi M, Harawa T, Corbett EL, Chaisson RE, Dowdy DW. Screening for Tuberculosis Among Adults Newly Diagnosed With HIV in Sub-Saharan Africa: A Cost-Effectiveness Analysis. Journal of Acquired Immune Deficiency Syndromes (1999). 70: 83-90. PMID 26049281 DOI: 10.1097/QAI.0000000000000712  0.84
2015 Getahun H, Matteelli A, Chaisson RE, Raviglione M. Latent Mycobacterium tuberculosis infection. The New England Journal of Medicine. 372: 2127-35. PMID 26017823 DOI: 10.1056/NEJMra1405427  0.84
2015 Hoffmann CJ, Hoffmann JD, Kensler C, van der Watt M, Omar T, Chaisson RE, Martinson NA, Variava E. Tuberculosis and hepatic steatosis are prevalent liver pathology findings among HIV-infected patients in South Africa. Plos One. 10: e0117813. PMID 25668620 DOI: 10.1371/journal.pone.0117813  0.84
2015 Golub JE, Cohn S, Saraceni V, Cavalcante SC, Pacheco AG, Moulton LH, Durovni B, Chaisson RE. Long-term protection from isoniazid preventive therapy for tuberculosis in HIV-infected patients in a medium-burden tuberculosis setting: the TB/HIV in Rio (THRio) study. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 60: 639-45. PMID 25365974 DOI: 10.1093/cid/ciu849  0.84
2015 Dooley KE, Denti P, Martinson N, Cohn S, Mashabela F, Hoffmann J, Haas DW, Hull J, Msandiwa R, Castel S, Wiesner L, Chaisson RE, McIlleron H. Pharmacokinetics of efavirenz and treatment of HIV-1 among pregnant women with and without tuberculosis coinfection. The Journal of Infectious Diseases. 211: 197-205. PMID 25081933 DOI: 10.1093/infdis/jiu429  0.84
2014 Chaisson RE, Post WS. Immunotherapy for tuberculous pericarditis. The New England Journal of Medicine. 371: 2535. PMID 25548814 DOI: 10.1056/NEJMc1413185  0.84
2014 Churchyard GJ, Chaisson RE, Maartens G, Getahun H. Tuberculosis preventive therapy: an underutilised strategy to reduce individual risk of TB and contribute to TB control. South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde. 104: 339-43. PMID 25212199 DOI: 10.7196/SAMJ.8290  0.84
2014 Chaisson RE, Post WS. Immunotherapy for tuberculous pericarditis. The New England Journal of Medicine. 371: 1155-7. PMID 25178808 DOI: 10.1056/NEJMe1409356  0.84
2014 Tiam A, Machekano R, Gounder CR, Maama-Maime LB, Ntene-Sealiete K, Sahu M, Isavwa A, Oyebanji O, Ahimbisibwe A, Mokone M, Barnes GL, Chaisson RE, Guay L, Kassaye S. Preventing tuberculosis among HIV-infected pregnant women in Lesotho: the case for rolling out active case finding and isoniazid preventive therapy. Journal of Acquired Immune Deficiency Syndromes (1999). 67: e5-e11. PMID 25118796 DOI: 10.1097/QAI.0000000000000209  0.84
2014 Saraceni V, Durovni B, Pacheco AG, Chaisson RE, Golub JE. Reply to "at the crossroads between early or delayed antiretroviral therapy initiation during TB/HIV coinfection". The Brazilian Journal of Infectious Diseases : An Official Publication of the Brazilian Society of Infectious Diseases. 18: 578-9. PMID 25108220 DOI: 10.1016/j.bjid.2014.07.001  0.84
2014 Kass NE, DeLuca AN, Coetzee L, Simwinga M, Churchyard GJ, Ayles H, Beyers N, Godfrey-Faussett P, Durovni B, Chaisson RE, Eldred LJ. Applying ethical principles to international community-based research: a case study from the Consortium to Respond Effectively to the AIDS-TB Epidemic (CREATE) . Irb. 36: 1-8. PMID 24946506  0.84
2014 Saraceni V, Cohn S, Cavalcante SC, Pacheco AG, Moulton LH, Chaisson RE, Durovni B, Golub JE. Prevalent tuberculosis at HIV diagnosis in Rio de Janeiro, Brazil: the TB/HIV in Rio (THRio) Cohort. Journal of Acquired Immune Deficiency Syndromes (1999). 67: 98-101. PMID 24933097 DOI: 10.1097/QAI.0000000000000247  0.84
2014 Hoffmann CJ, Mashabela F, Cohn S, Hoffmann JD, Lala S, Martinson NA, Chaisson RE. Maternal hepatitis B and infant infection among pregnant women living with HIV in South Africa. Journal of the International Aids Society. 17: 18871. PMID 24855985  0.36
2014 Dowdy DW, Golub JE, Saraceni V, Moulton LH, Cavalcante SC, Cohn S, Pacheco AG, Chaisson RE, Durovni B. Impact of isoniazid preventive therapy for HIV-infected adults in Rio de Janeiro, Brazil: an epidemiological model. Journal of Acquired Immune Deficiency Syndromes (1999). 66: 552-8. PMID 24853308 DOI: 10.1097/QAI.0000000000000219  0.84
2014 Martinson NA, Gupte N, Msandiwa R, Moulton LH, Barnes GL, Ram M, Gray G, Hoffmann C, Chaisson RE. CD4 and viral load dynamics in antiretroviral-naïve HIV-infected adults from Soweto, South Africa: a prospective cohort. Plos One. 9: e96369. PMID 24831447 DOI: 10.1371/journal.pone.0096369  0.84
2014 Saraceni V, Durovni B, Cavalcante SC, Cohn S, Pacheco AG, Moulton LH, Chaisson RE, Golub JE. Survival of HIV patients with tuberculosis started on simultaneous or deferred HAART in the THRio cohort, Rio de Janeiro, Brazil. The Brazilian Journal of Infectious Diseases : An Official Publication of the Brazilian Society of Infectious Diseases. 18: 491-5. PMID 24780362 DOI: 10.1016/j.bjid.2014.02.004  0.84
2014 Chaisson RE, Deluca A. Taking the long view on the CREATE studies' findings. The Lancet. Infectious Diseases. 14: 366-7. PMID 24758988 DOI: 10.1016/S1473-3099(14)70735-2  0.84
2014 Hoffmann CJ, Charalambous S, Grant AD, Morris L, Churchyard GJ, Chaisson RE. Durable HIV RNA resuppression after virologic failure while remaining on a first-line regimen: a cohort study. Tropical Medicine & International Health : Tm & Ih. 19: 236-9. PMID 24588012  0.36
2014 Beyrer C, Baral SD, Weir BW, Curran JW, Chaisson RE, Sullivan PS. A call to action for concentrated HIV epidemics. Current Opinion in Hiv and Aids. 9: 95-100. PMID 24499807 DOI: 10.1097/COH.0000000000000043  0.84
2014 Hoffmann CJ, Chaisson RE, Martinson NA. Cotrimoxazole prophylaxis and tuberculosis risk among people living with HIV. Plos One. 9: e83750. PMID 24421903 DOI: 10.1371/journal.pone.0083750  0.84
2014 Mexas F, Efron A, Luiz RR, Cailleaux-Cezar M, Chaisson RE, Conde MB. Understanding and retention of trial-related information among participants in a clinical trial after completing the informed consent process. Clinical Trials (London, England). 11: 70-6. PMID 24296322 DOI: 10.1177/1740774513509316  0.84
2014 Sterling TR, Chaisson RE. General Clinical Manifestations of Human Immunodeficiency Virus Infection (Including Acute Retroviral Syndrome and Oral, Cutaneous, Renal, Ocular, Metabolic, and Cardiac Diseases) Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. 1: 1541.e1-1557.e5. DOI: 10.1016/B978-1-4557-4801-3.00124-7  0.84
2013 Durovni B, Saraceni V, Moulton LH, Pacheco AG, Cavalcante SC, King BS, Cohn S, Efron A, Chaisson RE, Golub JE. Effect of improved tuberculosis screening and isoniazid preventive therapy on incidence of tuberculosis and death in patients with HIV in clinics in Rio de Janeiro, Brazil: a stepped wedge, cluster-randomised trial. The Lancet. Infectious Diseases. 13: 852-8. PMID 23954450 DOI: 10.1016/S1473-3099(13)70187-7  0.84
2013 Hoffmann CJ, Ledwaba J, Li JF, Johnston V, Hunt G, Fielding KL, Chaisson RE, Churchyard GJ, Grant AD, Johnson JA, Charalambous S, Morris L. Resistance to tenofovir-based regimens during treatment failure of subtype C HIV-1 in South Africa. Antiviral Therapy. 18: 915-20. PMID 23751421 DOI: 10.3851/IMP2652  0.36
2013 Dierberg KL, Chaisson RE. Human immunodeficiency virus-associated tuberculosis: update on prevention and treatment. Clinics in Chest Medicine. 34: 217-28. PMID 23702172 DOI: 10.1016/j.ccm.2013.02.003  0.84
2013 Hoffmann CJ, Variava E, Rakgokong M, Masonoke K, van der Watt M, Chaisson RE, Martinson NA. High prevalence of pulmonary tuberculosis but low sensitivity of symptom screening among HIV-infected pregnant women in South Africa. Plos One. 8: e62211. PMID 23614037 DOI: 10.1371/journal.pone.0062211  0.36
2013 Hoffmann CJ, Lewis JJ, Dowdy DW, Fielding KL, Grant AD, Martinson NA, Churchyard GJ, Chaisson RE. Mortality associated with delays between clinic entry and ART initiation in resource-limited settings: results of a transition-state model. Journal of Acquired Immune Deficiency Syndromes (1999). 63: 105-11. PMID 23392457 DOI: 10.1097/QAI.0b013e3182893fb4  0.84
2013 Duwell MM, Knowlton AR, Nachega JB, Efron A, Goliath R, Morroni C, Maartens G, Chaisson RE. Patient-nominated, community-based HIV treatment supporters: patient perspectives, feasibility, challenges, and factors for success in HIV-infected South African adults. Aids Patient Care and Stds. 27: 96-102. PMID 23373664 DOI: 10.1089/apc.2012.0348  0.84
2013 Dowdy DW, Chaisson RE. Post-2015 tuberculosis strategies in a pre-2015 world. The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease. 17: 143. PMID 23317946 DOI: 10.5588/ijtld.12.0966  0.84
2013 Otwombe KN, Variava E, Holmes CB, Chaisson RE, Martinson N. Predictors of delay in the diagnosis and treatment of suspected tuberculosis in HIV co-infected patients in South Africa International Journal of Tuberculosis and Lung Disease. 17: 1199-1205. DOI: 10.5588/ijtld.12.0891  0.84
2012 Nachega JB, Morroni C, Chaisson RE, Goliath R, Efron A, Ram M, Maartens G. Impact of immune reconstitution inflammatory syndrome on antiretroviral therapy adherence. Patient Preference and Adherence. 6: 887-91. PMID 23271897 DOI: 10.2147/PPA.S38897  0.84
2012 Gounder CR, Chaisson RE. A diagonal approach to building primary healthcare systems in resource-limited settings: women-centred integration of HIV/AIDS, tuberculosis, malaria, MCH and NCD initiatives. Tropical Medicine & International Health : Tm & Ih. 17: 1426-31. PMID 23113824 DOI: 10.1111/j.1365-3156.2012.03100.x  0.84
2012 Dowdy DW, Gounder CR, Corbett EL, Ngwira LG, Chaisson RE, Merritt MW. The ethics of testing a test: randomized trials of the health impact of diagnostic tests for infectious diseases. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 55: 1522-6. PMID 22918990 DOI: 10.1093/cid/cis736  0.84
2012 Suthar AB, Lawn SD, del Amo J, Getahun H, Dye C, Sculier D, Sterling TR, Chaisson RE, Williams BG, Harries AD, Granich RM. Antiretroviral therapy for prevention of tuberculosis in adults with HIV: a systematic review and meta-analysis. Plos Medicine. 9: e1001270. PMID 22911011 DOI: 10.1371/journal.pmed.1001270  0.84
2012 Chaisson RE, Nuermberger EL. Confronting multidrug-resistant tuberculosis. The New England Journal of Medicine. 366: 2223-4. PMID 22670908 DOI: 10.1056/NEJMe1204478  0.84
2012 Dowdy DW, Golub JE, Chaisson RE, Saraceni V. Heterogeneity in tuberculosis transmission and the role of geographic hotspots in propagating epidemics. Proceedings of the National Academy of Sciences of the United States of America. 109: 9557-62. PMID 22645356 DOI: 10.1073/pnas.1203517109  0.84
2012 Shapiro AE, Variava E, Rakgokong MH, Moodley N, Luke B, Salimi S, Chaisson RE, Golub JE, Martinson NA. Community-based targeted case finding for tuberculosis and HIV in household contacts of patients with tuberculosis in South Africa. American Journal of Respiratory and Critical Care Medicine. 185: 1110-6. PMID 22427532 DOI: 10.1164/rccm.201111-1941OC  0.84
2012 Hsia EC, Schluger N, Cush JJ, Chaisson RE, Matteson EL, Xu S, Beutler A, Doyle MK, Hsu B, Rahman MU. Interferon-γ release assay versus tuberculin skin test prior to treatment with golimumab, a human anti-tumor necrosis factor antibody, in patients with rheumatoid arthritis, psoriatic arthritis, or ankylosing spondylitis. Arthritis and Rheumatism. 64: 2068-77. PMID 22238071 DOI: 10.1002/art.34382  0.84
2012 Chaisson RE, Nuermberger EL. The editorialists reply New England Journal of Medicine. 367: 2155-2156. DOI: 10.1056/NEJMc1210001  0.84
2012 Page KR, Chaisson RE, Sande M. Cryptococcosis and other fungal infections (histoplasmosis and coccidioidomycosis) in HIV-infected patients Sande's Hiv/Aids Medicine: Medical Management of Aids 2013: Second Edition. 369-388. DOI: 10.1016/B978-1-4557-0695-2.00029-8  0.84
2011 Sterling TR, Villarino ME, Borisov AS, Shang N, Gordin F, Bliven-Sizemore E, Hackman J, Hamilton CD, Menzies D, Kerrigan A, Weis SE, Weiner M, Wing D, Conde MB, Bozeman L, ... ... Chaisson RE, et al. Three months of rifapentine and isoniazid for latent tuberculosis infection. The New England Journal of Medicine. 365: 2155-66. PMID 22150035 DOI: 10.1056/NEJMoa1104875  0.84
2011 Hoffmann CJ, Fielding KL, Johnston V, Charalambous S, Innes C, Moore RD, Chaisson RE, Grant AD, Churchyard GJ. Changing predictors of mortality over time from cART start: implications for care. Journal of Acquired Immune Deficiency Syndromes (1999). 58: 269-76. PMID 21876447 DOI: 10.1097/QAI.0b013e31823219d1  0.36
2011 Farley JE, Ram M, Pan W, Waldman S, Cassell GH, Chaisson RE, Weyer K, Lancaster J, Van der Walt M. Outcomes of multi-drug resistant tuberculosis (MDR-TB) among a cohort of South African patients with high HIV prevalence. Plos One. 6: e20436. PMID 21799728 DOI: 10.1371/journal.pone.0020436  0.84
2011 Martinson NA, Barnes GL, Moulton LH, Msandiwa R, Hausler H, Ram M, McIntyre JA, Gray GE, Chaisson RE. New regimens to prevent tuberculosis in adults with HIV infection. The New England Journal of Medicine. 365: 11-20. PMID 21732833 DOI: 10.1056/NEJMoa1005136  0.84
2011 Saraceni V, Pacheco AG, Golub JE, Vellozo V, King BS, Cavalcante SC, Eldred L, Chaisson RE, Durovni B. Physician adherence to guidelines for tuberculosis and HIV care in Rio de Janeiro, Brazil. The Brazilian Journal of Infectious Diseases : An Official Publication of the Brazilian Society of Infectious Diseases. 15: 249-52. PMID 21670926 DOI: 10.1016/S1413-8670(11)70184-2  0.84
2011 Martinson NA, Hoffmann CJ, Chaisson RE. Epidemiology of tuberculosis and HIV: recent advances in understanding and responses. Proceedings of the American Thoracic Society. 8: 288-93. PMID 21653530 DOI: 10.1513/pats.201010-064WR  0.84
2011 Crothers K, Thompson BW, Burkhardt K, Morris A, Flores SC, Diaz PT, Chaisson RE, Kirk GD, Rom WN, Huang L. HIV-associated lung infections and complications in the era of combination antiretroviral therapy. Proceedings of the American Thoracic Society. 8: 275-81. PMID 21653528 DOI: 10.1513/pats.201009-059WR  0.84
2011 Martinson NA, Chaisson RE. Survival in XDR TB: shifting the curve and shifting the paradigm. Journal of Acquired Immune Deficiency Syndromes (1999). 57: 89-91. PMID 21522018 DOI: 10.1097/QAI.0b013e31821b4b42  0.84
2011 Churchyard GJ, Fielding K, Roux S, Corbett EL, Chaisson RE, De Cock KM, Hayes RJ, Grant AD. Twelve-monthly versus six-monthly radiological screening for active case-finding of tuberculosis: a randomised controlled trial. Thorax. 66: 134-9. PMID 21098802 DOI: 10.1136/thx.2010.139048  0.84
2011 Pacheco AG, Saraceni V, Tuboi SH, Lauria LM, Moulton LH, Faulhaber JC, King B, Golub JE, Durovni B, Cavalcante S, Harrison LH, Chaisson RE, Schechter M. Estimating the extent of underreporting of mortality among HIV-infected individuals in Rio de Janeiro, Brazil. Aids Research and Human Retroviruses. 27: 25-8. PMID 20929394 DOI: 10.1089/aid.2010.0089  0.84
2010 Durovni B, Cavalcante SC, Saraceni V, Vellozo V, Israel G, King BS, Cohn S, Efron A, Pacheco AG, Moulton LH, Chaisson RE, Golub JE. The implementation of isoniazid preventive therapy in HIV clinics: the experience from the TB/HIV in Rio (THRio) study. Aids (London, England). 24: S49-56. PMID 21079428 DOI: 10.1097/01.aids.0000391022.95412.a6  0.84
2010 Grant AD, Fielding KL, Charalambous S, Chaisson RE, Churchyard GJ. Why have trials of isoniazid preventive therapy among people with HIV infection not demonstrated an effect on mortality?: did close examination of the trees obscure our view of the wood? Aids (London, England). 24: S15-8. PMID 21079423 DOI: 10.1097/01.aids.0000391011.40892.ff  0.84
2010 Chaisson RE, Harrington M. How research can help control tuberculosis World Hospitals and Health Services : the Official Journal of the International Hospital Federation. 46: 33-40. PMID 20614683  0.84
2010 Hanrahan CF, Golub JE, Mohapi L, Tshabangu N, Modisenyane T, Chaisson RE, Gray GE, McIntyre JA, Martinson NA. Body mass index and risk of tuberculosis and death. Aids (London, England). 24: 1501-8. PMID 20505496 DOI: 10.1097/QAD.0b013e32833a2a4a  0.84
2010 Hoffmann CJ, Fielding KL, Charalambous S, Innes C, Chaisson RE, Grant AD, Churchyard GJ. Reducing mortality with cotrimoxazole preventive therapy at initiation of antiretroviral therapy in South Africa. Aids (London, England). 24: 1709-16. PMID 20495439 DOI: 10.1097/QAD.0b013e32833ac6bc  0.84
2010 Nachega JB, Chaisson RE, Goliath R, Efron A, Chaudhary MA, Ram M, Morroni C, Schoeman H, Knowlton AR, Maartens G. Randomized controlled trial of trained patient-nominated treatment supporters providing partial directly observed antiretroviral therapy. Aids (London, England). 24: 1273-80. PMID 20453627 DOI: 10.1097/QAD.0b013e328339e20e  0.84
2010 Sterling TR, Pham PA, Chaisson RE. HIV infection-related tuberculosis: clinical manifestations and treatment. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 50: S223-30. PMID 20397952 DOI: 10.1086/651495  0.84
2010 Pope DS, Atkins S, DeLuca AN, Hausler H, Hoosain E, Celentano DD, Chaisson RE. South African TB nurses' experiences of provider-initiated HIV counseling and testing in the Eastern Cape Province: a qualitative study. Aids Care. 22: 238-45. PMID 20390502 DOI: 10.1080/09540120903040594  0.84
2010 Guerra RL, Conde MB, Efron A, Loredo C, Bastos G, Chaisson RE, Golub JE. Point-of-care Arkansas method for measuring adherence to treatment with isoniazid. Respiratory Medicine. 104: 754-7. PMID 20202806 DOI: 10.1016/j.rmed.2010.02.001  0.84
2010 Chaisson RE, Churchyard GJ. Recurrent tuberculosis: relapse, reinfection, and HIV. The Journal of Infectious Diseases. 201: 653-5. PMID 20121432 DOI: 10.1086/650531  0.84
2009 Dooley KE, Chaisson RE. Tuberculosis and diabetes mellitus: convergence of two epidemics. The Lancet. Infectious Diseases. 9: 737-46. PMID 19926034 DOI: 10.1016/S1473-3099(09)70282-8  0.84
2009 Hoffmann CJ, Charalambous S, Sim J, Ledwaba J, Schwikkard G, Chaisson RE, Fielding KL, Churchyard GJ, Morris L, Grant AD. Viremia, resuppression, and time to resistance in human immunodeficiency virus (HIV) subtype C during first-line antiretroviral therapy in South Africa. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 49: 1928-35. PMID 19911963 DOI: 10.1086/648444  0.36
2009 Shah M, Variava E, Holmes CB, Coppin A, Golub JE, McCallum J, Wong M, Luke B, Martin DJ, Chaisson RE, Dorman SE, Martinson NA. Diagnostic accuracy of a urine lipoarabinomannan test for tuberculosis in hospitalized patients in a High HIV prevalence setting. Journal of Acquired Immune Deficiency Syndromes (1999). 52: 145-51. PMID 19692904 DOI: 10.1097/QAI.0b013e3181b98430  0.84
2009 Golub JE, Chaisson RE, Martinson NA. Additive effects of isoniazid preventive therapy and HAART. Aids (London, England). 23: 1446-7. PMID 19564725 DOI: 10.1097/QAD.0b013e32832d53fc  0.84
2009 Dowdy DW, Chaisson RE. The persistence of tuberculosis in the age of DOTS: reassessing the effect of case detection. Bulletin of the World Health Organization. 87: 296-304. PMID 19551238 DOI: 10.2471/BLT.08.054510  0.84
2009 Golub JE, Pronyk P, Mohapi L, Thsabangu N, Moshabela M, Struthers H, Gray GE, McIntyre JA, Chaisson RE, Martinson NA. Isoniazid preventive therapy, HAART and tuberculosis risk in HIV-infected adults in South Africa: a prospective cohort. Aids (London, England). 23: 631-6. PMID 19525621 DOI: 10.1097/QAD.0b013e328327964f  0.84
2009 Hoffmann CJ, Charalambous S, Fielding KL, Innes C, Chaisson RE, Grant AD, Churchyard GJ. HIV suppression with stavudine 30 mg versus 40 mg in adults over 60 kg on antiretroviral therapy in South Africa. Aids (London, England). 23: 1784-6. PMID 19491652 DOI: 10.1097/QAD.0b013e32832e0585  0.84
2009 Dorman SE, Johnson JL, Goldberg S, Muzanye G, Padayatchi N, Bozeman L, Heilig CM, Bernardo J, Choudhri S, Grosset JH, Guy E, Guyadeen P, Leus MC, Maltas G, Menzies D, ... ... Chaisson RE, et al. Substitution of moxifloxacin for isoniazid during intensive phase treatment of pulmonary tuberculosis. American Journal of Respiratory and Critical Care Medicine. 180: 273-80. PMID 19406981 DOI: 10.1164/rccm.200901-0078OC  0.84
2009 Conde MB, Efron A, Loredo C, De Souza GR, Graça NP, Cezar MC, Ram M, Chaudhary MA, Bishai WR, Kritski AL, Chaisson RE. Moxifloxacin versus ethambutol in the initial treatment of tuberculosis: a double-blind, randomised, controlled phase II trial. Lancet (London, England). 373: 1183-9. PMID 19345831 DOI: 10.1016/S0140-6736(09)60333-0  0.84
2009 Nachega JB, Hislop M, Nguyen H, Dowdy DW, Chaisson RE, Regensberg L, Cotton M, Maartens G. Antiretroviral therapy adherence, virologic and immunologic outcomes in adolescents compared with adults in southern Africa. Journal of Acquired Immune Deficiency Syndromes (1999). 51: 65-71. PMID 19282780 DOI: 10.1097/QAI.0b013e318199072e  0.84
2009 Ribeiro S, Dooley K, Hackman J, Loredo C, Efron A, Chaisson RE, Conde MB, Boechat N, Dorman SE. T-SPOT.TB responses during treatment of pulmonary tuberculosis. Bmc Infectious Diseases. 9: 23. PMID 19250549 DOI: 10.1186/1471-2334-9-23  0.84
2009 Deluca A, Chaisson RE, Martinson NA. Intensified case finding for tuberculosis in prevention of mother-to-child transmission programs: a simple and potentially vital addition for maternal and child health. Journal of Acquired Immune Deficiency Syndromes (1999). 50: 196-9. PMID 19131888 DOI: 10.1097/QAI.0b013e3181900201  0.84
2009 Dowdy DW, Chaisson RE. Author reply Bulletin of the World Health Organization. 87. DOI: 10.2471/BLT.09.071282  0.84
2009 Chaisson RE, Chaudhary MA, Conde MB. Moxifloxacin versus ethambutol in initial tuberculosis treatment - Authors' reply The Lancet. 373: 2198-2199. DOI: 10.1016/S0140-6736(09)61190-9  0.84
2009 Dorman SE, Johnson JL, Chaisson RE. From the authors American Journal of Respiratory and Critical Care Medicine. 180: 686-687.  0.84
2008 Dowdy DW, Lourenço MC, Cavalcante SC, Saraceni V, King B, Golub JE, Bishai D, Durovni B, Chaisson RE, Dorman SE. Impact and cost-effectiveness of culture for diagnosis of tuberculosis in HIV-infected Brazilian adults. Plos One. 3: e4057. PMID 19129940 DOI: 10.1371/journal.pone.0004057  0.84
2008 Golub JE, Durovni B, King BS, Cavalacante SC, Pacheco AG, Moulton LH, Moore RD, Chaisson RE, Saraceni V. Recurrent tuberculosis in HIV-infected patients in Rio de Janeiro, Brazil. Aids (London, England). 22: 2527-33. PMID 19005276 DOI: 10.1097/QAD.0b013e328311ac4e  0.84
2008 Golub JE, Astemborski J, Ahmed M, Cronin W, Mehta SH, Kirk GD, Vlahov D, Chaisson RE. Long-term effectiveness of diagnosing and treating latent tuberculosis infection in a cohort of HIV-infected and at-risk injection drug users. Journal of Acquired Immune Deficiency Syndromes (1999). 49: 532-7. PMID 18989223 DOI: 10.1097/QAI.0b013e31818d5c1c  0.84
2008 Hoffmann CJ, Charalambous S, Martin DJ, Innes C, Churchyard GJ, Chaisson RE, Grant AD, Fielding KL, Thio CL. Hepatitis B virus infection and response to antiretroviral therapy (ART) in a South African ART program. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 47: 1479-85. PMID 18937580 DOI: 10.1086/593104  0.36
2008 Pacheco AG, Saraceni V, Tuboi SH, Moulton LH, Chaisson RE, Cavalcante SC, Durovni B, Faulhaber JC, Golub JE, King B, Schechter M, Harrison LH. Validation of a hierarchical deterministic record-linkage algorithm using data from 2 different cohorts of human immunodeficiency virus-infected persons and mortality databases in Brazil. American Journal of Epidemiology. 168: 1326-32. PMID 18849301 DOI: 10.1093/aje/kwn249  0.84
2008 Nachega JB, Hislop M, Dowdy DW, Gallant JE, Chaisson RE, Regensberg L, Maartens G. Efavirenz versus nevirapine-based initial treatment of HIV infection: clinical and virological outcomes in Southern African adults. Aids (London, England). 22: 2117-25. PMID 18832875 DOI: 10.1097/QAD.0b013e328310407e  0.84
2008 Pacheco AG, Durovni B, Cavalcante SC, Lauria LM, Moore RD, Moulton LH, Chaisson RE, Golub JE. AIDS-related tuberculosis in Rio de Janeiro, Brazil. Plos One. 3: e3132. PMID 18781195 DOI: 10.1371/journal.pone.0003132  0.84
2008 Dooley K, Flexner C, Hackman J, Peloquin CA, Nuermberger E, Chaisson RE, Dorman SE. Repeated administration of high-dose intermittent rifapentine reduces rifapentine and moxifloxacin plasma concentrations. Antimicrobial Agents and Chemotherapy. 52: 4037-42. PMID 18765687 DOI: 10.1128/AAC.00554-08  0.84
2008 Dowdy DW, Chaisson RE, Maartens G, Corbett EL, Dorman SE. Impact of enhanced tuberculosis diagnosis in South Africa: a mathematical model of expanded culture and drug susceptibility testing. Proceedings of the National Academy of Sciences of the United States of America. 105: 11293-8. PMID 18695217 DOI: 10.1073/pnas.0800965105  0.84
2008 Pope DS, Deluca AN, Kali P, Hausler H, Sheard C, Hoosain E, Chaudhary MA, Celentano DD, Chaisson RE. A cluster-randomized trial of provider-initiated (opt-out) HIV counseling and testing of tuberculosis patients in South Africa. Journal of Acquired Immune Deficiency Syndromes (1999). 48: 190-5. PMID 18520677 DOI: 10.1097/QAI.0b013e3181775926  0.84
2008 Chaisson RE, Martinson NA. Tuberculosis in Africa--combating an HIV-driven crisis. The New England Journal of Medicine. 358: 1089-92. PMID 18337598 DOI: 10.1056/NEJMp0800809  0.84
2008 Hoffmann CJ, Fielding KL, Charalambous S, Sulkowski MS, Innes C, Thio CL, Chaisson RE, Churchyard GJ, Grant AD. Antiretroviral therapy using zidovudine, lamivudine, and efavirenz in South Africa: tolerability and clinical events. Aids (London, England). 22: 67-74. PMID 18090393 DOI: 10.1097/QAD.0b013e3282f2306e  0.36
2007 Rosenthal IM, Zhang M, Williams KN, Peloquin CA, Tyagi S, Vernon AA, Bishai WR, Chaisson RE, Grosset JH, Nuermberger EL. Daily dosing of rifapentine cures tuberculosis in three months or less in the murine model. Plos Medicine. 4: e344. PMID 18092886 DOI: 10.1371/journal.pmed.0040344  0.84
2007 Mello FC, Arias MS, Rosales S, Marsico AG, Pavón A, Alvarado-Gálvez C, Pessôa CL, Pérez M, Andrade MK, Kritski AL, Fonseca LS, Chaisson RE, Kimerling ME, Dorman SE. Clinical evaluation of the microscopic observation drug susceptibility assay for detection of Mycobacterium tuberculosis resistance to isoniazid or rifampin. Journal of Clinical Microbiology. 45: 3387-9. PMID 17699652 DOI: 10.1128/JCM.00580-07  0.84
2007 Churchyard GJ, Scano F, Grant AD, Chaisson RE. Tuberculosis preventive therapy in the era of HIV infection: overview and research priorities. The Journal of Infectious Diseases. 196: S52-62. PMID 17624827 DOI: 10.1086/518662  0.84
2007 Golub JE, Saraceni V, Cavalcante SC, Pacheco AG, Moulton LH, King BS, Efron A, Moore RD, Chaisson RE, Durovni B. The impact of antiretroviral therapy and isoniazid preventive therapy on tuberculosis incidence in HIV-infected patients in Rio de Janeiro, Brazil. Aids (London, England). 21: 1441-8. PMID 17589190 DOI: 10.1097/QAD.0b013e328216f441  0.84
2007 Hoffmann CJ, Charalambous S, Thio CL, Martin DJ, Pemba L, Fielding KL, Churchyard GJ, Chaisson RE, Grant AD. Hepatotoxicity in an African antiretroviral therapy cohort: the effect of tuberculosis and hepatitis B. Aids (London, England). 21: 1301-8. PMID 17545706 DOI: 10.1097/QAD.0b013e32814e6b08  0.36
2007 Moulton LH, Golub JE, Durovni B, Cavalcante SC, Pacheco AG, Saraceni V, King B, Chaisson RE. Statistical design of THRio: a phased implementation clinic-randomized study of a tuberculosis preventive therapy intervention. Clinical Trials (London, England). 4: 190-9. PMID 17456522 DOI: 10.1177/1740774507076937  0.84
2007 Dorman SE, Chaisson RE. From magic bullets back to the Magic Mountain: The rise of extensively drug-resistant tuberculosis - Commentary Nature Medicine. 13: 295-298. PMID 17342143 DOI: 10.1038/nm0307-295  0.84
2007 Mohan CI, Bishai D, Cavalcante S, Chaisson RE. The cost-effectiveness of DOTS in urban Brazil International Journal of Tuberculosis and Lung Disease. 11: 27-32. PMID 17217126  0.84
2006 Dowdy DW, Chaisson RE, Moulton LH, Dorman SE. The potential impact of enhanced diagnostic techniques for tuberculosis driven by HIV: a mathematical model. Aids (London, England). 20: 751-62. PMID 16514306 DOI: 10.1097/01.aids.0000216376.07185.cc  0.84
2005 Golub JE, Mohan CI, Comstock GW, Chaisson RE. Active case finding of tuberculosis: Historical perspective and future prospects International Journal of Tuberculosis and Lung Disease. 9: 1183-1203. PMID 16333924  0.84
2005 Wilson D, Nachega JB, Chaisson RE, Maartens G. Diagnostic yield of peripheral lymph node needle-core biopsies in HIV-infected adults with suspected smear-negative tuberculosis International Journal of Tuberculosis and Lung Disease. 9: 220-222. PMID 15732745  0.84
2004 Sulkowski MS, Mehta SH, Chaisson RE, Thomas DL, Moore RD. Hepatotoxicity associated with protease inhibitor-based antiretroviral regimens with or without concurrent ritonavir. Aids (London, England). 18: 2277-84. PMID 15577540 DOI: 10.1097/00002030-200411190-00008  0.84
2004 Gordin FM, Cohn DL, Matts JP, Chaisson RE, O'Brien RJ. Hepatotoxicity of rifampin and pyrazinamide in the treatment of latent tuberculosis infection in HIV-infected persons: Is it different than in HIV-uninfected persons? Clinical Infectious Diseases. 39: 561-565. PMID 15356822 DOI: 10.1086/422724  0.84
2004 Karakousis PC, Moore RD, Chaisson RE. Mycobacterium avium complex in patients with HIV infection in the era of highly active antiretroviral therapy. The Lancet. Infectious Diseases. 4: 557-65. PMID 15336223 DOI: 10.1016/S1473-3099(04)01130-2  0.84
2004 Moore RD, Keruly JC, Chaisson RE. Differences in HIV disease progression by injecting drug use in HIV-infected persons in care. Journal of Acquired Immune Deficiency Syndromes (1999). 35: 46-51. PMID 14707791 DOI: 10.1097/00126334-200401010-00006  0.84
2004 Wagner KR, Chaisson RE. Pulmonary Complications of HIV Infection Aids and Other Manifestations of Hiv Infection. 407-421. DOI: 10.1016/B978-012764051-8/50018-4  0.84
2003 Sterling TR, Chaisson RE, Keruly J, Moore RD. Improved outcomes with earlier initiation of highly active antiretroviral therapy among human immunodeficiency virus-infected patients who achieve durable virologic suppression: longer follow-up of an observational cohort study. The Journal of Infectious Diseases. 188: 1659-65. PMID 14639536 DOI: 10.1086/379741  0.84
2003 Chaisson RE. Treatment of chronic infections with rifamycins: Is resistance likely to follow? Antimicrobial Agents and Chemotherapy. 47: 3037-3039. PMID 14506005 DOI: 10.1128/AAC.47.10.3037-3039.2003  0.84
2003 Mehta SH, Moore RD, Thomas DL, Chaisson RE, Sulkowski MS. The effect of HAART and HCV infection on the development of hyperglycemia among HIV-infected persons. Journal of Acquired Immune Deficiency Syndromes (1999). 33: 577-84. PMID 12902801 DOI: 10.1097/00126334-200308150-00005  0.84
2003 Pope DS, Chaisson RE. TB treatment: as simple as DOT? The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease. 7: 611-5. PMID 12870680  0.84
2003 Lucas GM, Chaisson RE, Moore RD. Survival in an urban HIV-1 clinic in the era of highly active antiretroviral therapy: a 5-year cohort study. Journal of Acquired Immune Deficiency Syndromes (1999). 33: 321-8. PMID 12843742  0.84
2003 Chaisson RE. Tuberculosis Chemotherapy: Still a Double-edged Sword American Journal of Respiratory and Critical Care Medicine. 167: 1461-1462. PMID 12770849 DOI: 10.1164/rccm.2303004  0.84
2003 Sterling TR, Chaisson RE, Moore RD. Initiation of highly active antiretroviral therapy at CD4+ T lymphocyte counts of >350 cells/mm3: disease progression, treatment durability, and drug toxicity. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 36: 812-5. PMID 12627368 DOI: 10.1086/367934  0.84
2003 Nachega JB, Chaisson RE. Tuberculosis drug resistance: A global threat Clinical Infectious Diseases. 36. PMID 12516027 DOI: 10.1086/344657  0.84
2002 Park WG, Bishai WR, Chaisson RE, Dorman SE. Performance of the microscopic observation drug susceptibility assay in drug susceptibility testing for Mycobacterium tuberculosis. Journal of Clinical Microbiology. 40: 4750-2. PMID 12454186 DOI: 10.1128/JCM.40.12.4750-4752.2002  0.84
2002 Chaisson RE. TB and HIV: challenges and progress The Hopkins Hiv Report : a Bimonthly Newsletter For Healthcare Providers / Johns Hopkins University Aids Service. 14: 8-9. PMID 12206101  0.84
2002 Chaisson RE, Gebo K, Flexner C, Gallant JE, Lucas GM, Bartlett JG. Selected topics from the 9th Conference on Retroviruses and Opportunistic Infections. Hiv Clinical Trials. 3: 333-49. PMID 12187508 DOI: 10.1310/hct.2002.3.4.010  0.84
2002 Sulkowski MS, Moore RD, Mehta SH, Chaisson RE, Thomas DL. Hepatitis C and progression of HIV disease. Jama. 288: 199-206. PMID 12095384  0.84
2002 Chaisson RE, Armstrong J, Stafford J, Golub J, Bur S. Safety and tolerability of intermittent rifampin/pyrazinamide for the treatment of latent tuberculosis infection in prisoners [4] Journal of the American Medical Association. 288: 165-166. PMID 12095379  0.84
2002 Lucas GM, Gebo KA, Chaisson RE, Moore RD. Longitudinal assessment of the effects of drug and alcohol abuse on HIV-1 treatment outcomes in an urban clinic. Aids (London, England). 16: 767-74. PMID 11964533 DOI: 10.1097/00002030-200203290-00012  0.84
2002 Riley ED, Vlahov D, Huettner S, Beilenson P, Bonds M, Chaisson RE. Characteristics of injection drug users who utilize tuberculosis services at sites of the Baltimore City needle exchange program Journal of Urban Health. 79: 113-127. PMID 11937620 DOI: 10.1093/jurban/79.1.113  0.84
2002 Oursler KK, Moore RD, Bishai WR, Harrington SM, Pope DS, Chaisson RE. Survival of patients with pulmonary tuberculosis: clinical and molecular epidemiologic factors. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 34: 752-9. PMID 11850859 DOI: 10.1086/338784  0.84
2002 Sulkowski MS, Thomas DL, Mehta SH, Chaisson RE, Moore RD. Hepatotoxicity associated with nevirapine or efavirenz-containing antiretroviral therapy: Role of hepatitis C and B infections Hepatology. 35: 182-189. PMID 11786975 DOI: 10.1053/jhep.2002.30319  0.84
2001 Sterling TR, Chaisson RE, Moore RD. HIV-1 RNA, CD4 T-lymphocytes, and clinical response to highly active antiretroviral therapy Aids. 15: 2251-2257. PMID 11698698 DOI: 10.1097/00002030-200111230-00006  0.84
2001 Chaisson RE. AIDS turns 20: reflections on a brief but extraordinary history The Hopkins Hiv Report : a Bimonthly Newsletter For Healthcare Providers / Johns Hopkins University Aids Service. 13. PMID 11682850  0.84
2001 Keruly JC, Chaisson RE, Moore RD. Increasing incidence of avascular necrosis of the hip in HIV-infected patients [3] Journal of Acquired Immune Deficiency Syndromes. 28: 101-102. PMID 11579286  0.84
2001 Golub JE, Cronin WA, Obasanjo OO, Coggin W, Moore K, Pope DS, Thompson D, Sterling TR, Harrington S, Bishai WR, Chaisson RE. Transmission of Mycobacterium tuberculosis through casual contact with an infectious case. Archives of Internal Medicine. 161: 2254-8. PMID 11575983  0.84
2001 Lucas GM, Chaisson RE, Moore RD. Comparison of initial combination antiretroviral therapy with a single protease inhibitor, ritonavir and saquinavir, or efavirenz Aids. 15: 1679-1686. PMID 11546943 DOI: 10.1097/00002030-200109070-00011  0.84
2001 Lucas GM, Cheever LW, Chaisson RE, Moore RD. Detrimental effects of continued illicit drug use on the treatment of HIV-1 infection Journal of Acquired Immune Deficiency Syndromes. 27: 251-259. PMID 11464144  0.84
2001 Riley ED, Chaisson RE, Robnett TJ, Vertefeuille J, Strathdee SA, Vlahov D. Use of audio computer-assisted self-interviews to assess tuberculosis-related risk behaviors American Journal of Respiratory and Critical Care Medicine. 164: 82-85. PMID 11435243  0.84
2001 Poundstone KE, Chaisson RE, Moore RD. Differences in HIV disease progression by injection drug use and by sex in the era of highly active antiretroviral therapy Aids. 15: 1115-1123. PMID 11416713 DOI: 10.1097/00002030-200106150-00006  0.84
2001 Moore RD, Keruly JC, Chaisson RE. Incidence of pancreatitis in HIV-infected patients receiving nucleoside reverse transcriptase inhibitor drugs Aids. 15: 617-620. PMID 11316999 DOI: 10.1097/00002030-200103300-00011  0.84
2001 Bhalla A, Chaisson RE. Why blame private practitioners? [2] Chest. 119: 1288. PMID 11296207 DOI: 10.1378/chest.119.4.1288  0.84
2001 Kyriakides TC, Guarino P, Chaisson RE, Moore RD. Timing of antiretroviral treatment initiation [2] (multiple letters) Journal of the American Medical Association. 285: 1702-1703. PMID 11277817  0.84
2000 Chaisson RE. The world AIDS conference in Durban, South Africa--science, politics, and health The Hopkins Hiv Report : a Bimonthly Newsletter For Healthcare Providers / Johns Hopkins University Aids Service. 12. PMID 12184236  0.84
2000 Chaisson RE, Bartlett JG. Update on opportunistic infections The Hopkins Hiv Report : a Bimonthly Newsletter For Healthcare Providers / Johns Hopkins University Aids Service. 12. PMID 12184227  0.84
2000 Stringer JS, Youle M, Sabin C, Chaisson RE, Sterling TR. Selected topics from the 13th International AIDS Conference, July 9-14, 2000. Duran, South Africa. Hiv Clinical Trials. 1: 100-11. PMID 11590507 DOI: 10.1310/MKCR-W0MN-5BTD-5CLN  0.84
2000 Chaisson RE. Guidelines for the management of community-acquired pneumonia American Journal of Managed Care. 6. PMID 11187445  0.84
2000 Chaisson RE. New developments in the treatment of latent tuberculosis International Journal of Tuberculosis and Lung Disease. 4. PMID 11144550  0.84
2000 Chaisson RE, Keruly JC, Moore RD. Association of initial CD4 cell count and viral load with response to highly active antiretroviral therapy [6] (multiple letters) Journal of the American Medical Association. 284: 3128-3129. PMID 11135775  0.84
2000 Sullivan JH, Moore RD, Keruly JC, Chaisson RE. Effect of antiretroviral therapy on the incidence of bacterial pneumonia in patients with advanced HIV infection American Journal of Respiratory and Critical Care Medicine. 162: 64-67. PMID 10903221  0.84
2000 Velasco M, Guijarro C. Elevated liver enzymes following initiation of antiretroviral therapy. Jama. 283: 2526-7. PMID 10815112  0.84
2000 Rao SN, Mookerjee AL, Obasanjo OO, Chaisson RE. Errors in the treatment of tuberculosis in Baltimore Chest. 117: 734-737. PMID 10712999  0.84
2000 Sterling TR, Pope DS, Bishai WR, Harrington S, Gershon RR, Chaisson RE. Transmission of Mycobacterium tuberculosis from a cadaver to an embalmer. The New England Journal of Medicine. 342: 246-8. PMID 10648766 DOI: 10.1056/NEJM200001273420404  0.84
2000 Sulkowski MS, Thomas DL, Chaisson RE, Moore RD. Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection Journal of the American Medical Association. 283: 74-80. PMID 10632283  0.84
1999 Chaisson RE. Update on treatment and prevention guidelines for HIV-related tuberculosis The Hopkins Hiv Report : a Bimonthly Newsletter For Healthcare Providers / Johns Hopkins University Aids Service. 11. PMID 11367371  0.84
1999 Chaisson RE. HIV becomes world's leading infectious cause of death The Hopkins Hiv Report : a Bimonthly Newsletter For Healthcare Providers / Johns Hopkins University Aids Service. 11: 1. PMID 11366920  0.84
1999 Bishai WR, Chaisson RE. Opportunistic infections: down but not out The Hopkins Hiv Report : a Bimonthly Newsletter For Healthcare Providers / Johns Hopkins University Aids Service. 11. PMID 11366247  0.84
1999 Moore RD, Chaisson RE. Natural history of HIV infection in the era of combination antiretroviral therapy Aids. 13: 1933-1942. PMID 10513653 DOI: 10.1097/00002030-199910010-00017  0.84
1999 Miyazaki E, Chaisson RE, Bishai WR. Analysis of rifapentine for preventive therapy in the Cornell mouse model of latent tuberculosis Antimicrobial Agents and Chemotherapy. 43: 2126-2130. PMID 10471552  0.84
1999 Lucas GM, Chaisson RE, Moore RD. Highly active antiretroviral therapy in a large urban clinic: Risk factors for virologic failure and adverse drug reactions Annals of Internal Medicine. 131: 81-87. PMID 10419445  0.84
1999 De Cock KM, Chaisson RE. Will DOTS do it? A reappraisal of tuberculosis control in countries with high rates of HIV infection International Journal of Tuberculosis and Lung Disease. 3: 457-465. PMID 10383056  0.84
1999 Gebo KA, Chaisson RE, Folkemer JG, Bartlett JG, Moore RD. Costs of HIV medical care in the era of highly active antiretroviral therapy Aids. 13: 963-969. PMID 10371178 DOI: 10.1097/00002030-199905280-00013  0.84
1999 Oursler KAK, Moore RD, Chaisson RE. Risk factors for cryptococcal meningitis in HIV-infected patients Aids Research and Human Retroviruses. 15: 625-631. PMID 10331441 DOI: 10.1089/088922299310926  0.84
1999 Gallant JE, Chaisson RE, Keruly JC, Moore RD. Stavudine in zidovudine (ZDV)-experienced compared with ZDV-naive patients Aids. 13: 225-229. PMID 10202828 DOI: 10.1097/00002030-199902040-00010  0.84
1999 Sterling TR, Brehm WT, Moore RD, Chaisson RE. Tuberculosis vaccination versus isoniazid preventive therapy: A decision analysis to determine the preferred strategy of tuberculosis prevention in HIV-infected adults in the developing world International Journal of Tuberculosis and Lung Disease. 3: 248-254. PMID 10094327  0.84
1999 Chaisson RE, Coberiy JS, De Cock KM. Dots and drug resistance: A silver lining to a darkening cloud. Editorial International Journal of Tuberculosis and Lung Disease. 3: 1-3. PMID 10094162  0.84
1999 Moore RD, Cheever L, Keruly JC, Chaisson RE. Lack of sex difference in CD4 to HIV-1 RNA viral load ratio Lancet. 353: 463-464. PMID 9989720  0.84
1999 Miyazaki E, Miyazaki M, Chen JM, Chaisson RE, Bishai WR. Moxifloxacin (BAY12-8039), a new 8-methoxyquinolone, is active in a mouse model of tuberculosis Antimicrobial Agents and Chemotherapy. 43: 85-89. PMID 9869570  0.84
1999 Chaisson RE. Appropriate diagnosis and use of antimicrobial therapy in treating upper respiratory infections American Journal of Managed Care. 5.  0.84
1999 Bishai WR, Chaisson RE. Drug resistance and the treatment of upper respiratory infections American Journal of Managed Care. 5.  0.84
1998 Chaisson RE, Bishai W. No news is good news: opportunistic infections The Hopkins Hiv Report : a Bimonthly Newsletter For Healthcare Providers / Johns Hopkins University Aids Service. 10. PMID 11366129  0.84
1998 Chaisson RE. Short course preventive therapy for tuberculosis is successful in HIV-infected patients The Hopkins Hiv Report : a Bimonthly Newsletter For Healthcare Providers / Johns Hopkins University Aids Service. 10: 2-3. PMID 11365493  0.84
1998 Bishai WR, Graham NM, Harrington S, Pope DS, Hooper N, Astemborski J, Sheely L, Vlahov D, Glass GE, Chaisson RE. Molecular and geographic patterns of tuberculosis transmission after 15 years of directly observed therapy. Jama. 280: 1679-84. PMID 9831999  0.84
1998 Gallant JE, Chaisson RE, Moore RD. The effect of adjunctive corticosteroids for the treatment of Pneumocystis carinii pneumonia on mortality and subsequent complications Chest. 114: 1258-1263. PMID 9823998  0.84
1998 Morris L, Martin DJ, Quinn TC, Chaisson RE. The importance of doing HIV research in developing countries Nature Medicine. 4: 1228-1229. PMID 9809535 DOI: 10.1038/3206  0.84
1998 Moore RD, Keruly JC, Chaisson RE. Anemia and survival in HIV infection Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 19: 29-33. PMID 9732065  0.84
1998 Eldred LJ, Wu AW, Chaisson RE, Moore RD. Adherence to antiretroviral and pneumocystis prophylaxis in HIV disease Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 18: 117-125. PMID 9637576  0.84
1998 Chaisson RE, Gallant JE, Keruly JC, Moore RD. Impact of opportunistic disease on survival in patients with HIV infection Aids. 12: 29-33. PMID 9456252 DOI: 10.1097/00002030-199801000-00004  0.84
1997 Erbelding EJ, Chaisson RE, Gallant JE, Moore RD. Acyclovir in combination with zidovudine does not prolong survival in advanced HIV disease Antiviral Therapy. 2: 71-77. PMID 11322278  0.84
1997 Chaisson RE, Moore RD. Prevention of opportunistic infections in the era of improved antiretroviral therapy Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 16. PMID 9389311  0.84
1997 Moore RD, Chaisson RE. Cost-utility analysis of prophylactic treatment with oral ganciclovir for cytomegalovirus retinitis Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 16: 15-21. PMID 9377120  0.84
1997 Michele TM, Cronin WA, Graham NM, Dwyer DM, Pope DS, Harrington S, Chaisson RE, Bishai WR. Transmission of Mycobacterium tuberculosis by a fiberoptic bronchoscope. Identification by DNA fingerprinting. Jama. 278: 1093-5. PMID 9315769  0.84
1997 Styrt BA, Chaisson RE, Moore RD. Prior antimicrobials and staphylococcal bacteremia in HIV-infected patients Aids. 11: 1243-1248. PMID 9256942 DOI: 10.1097/00002030-199710000-00007  0.84
1997 Moore RD, Chaisson RE. Costs to medicaid of advancing immunosuppression in an urban HIV- infected patient population in Maryland Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 14: 223-231. PMID 9117454  0.84
1997 Bishai WR, Chaisson RE. Short-course chemoprophylaxis for tuberculosis Clinics in Chest Medicine. 18: 115-122. PMID 9098615 DOI: 10.1016/S0272-5231(05)70360-9  0.84
1997 Moore RD, Chaisson RE. Cost-effectiveness of prophylaxis for Mycobacterium avium complex disease American Journal of Medicine. 102: 50-55. DOI: 10.1016/S0002-9343(97)00201-5  0.84
1997 Cheever LW, Wolf L, Chaisson RE. MEMS devices to measure adherence among HIV infected patients Clinical Infectious Diseases. 25: 400.  0.84
1997 Chaisson RE, Keruly J, Gallant JE, Moore RD. Risk factors for bacterial pneumonia in MV disease Clinical Infectious Diseases. 25: 455.  0.84
1997 Oursler KK, Moore RD, Chaisson RE. Risk factors for cryptococcal meningitis in HIV-lnfected patients Clinical Infectious Diseases. 25: 453.  0.84
1997 Moore RD, Keruly JC, Chaisson RE. The effectiveness of combination antiretroviral therapy in clinical practice Clinical Infectious Diseases. 25: 395.  0.84
1997 Sterling TR, Moore RD, Gibson J, Astemborski J, Vlahov D, Chaisson RE. The impact of M. tuberculosis infection on subsequent disseminated MAC disease in KV-infected persons Clinical Infectious Diseases. 25: 447.  0.84
1996 Moore RD, Chaulk CP, Griffiths R, Cavalcante S, Chaisson RE. Cost-effectiveness of directly observed versus self-administered therapy for tuberculosis American Journal of Respiratory and Critical Care Medicine. 154: 1013-1019. PMID 8887600  0.84
1996 Cheever LW, Chaisson RE, Gallant JE. Prophylaxis against opportunistic infections in patients infected with the human immunodeficiency virus Western Journal of Medicine. 165: 67-73. PMID 8855697  0.84
1996 Chaisson RE. Potential role of rifabutin in prophylaxis for tuberculosis and infections due to multiple opportunistic pathogens Clinical Infectious Diseases. 22. PMID 8785259  0.84
1996 Moore RD, Fortgang I, Keruly J, Chaisson RE. Adverse events from drug therapy for human immunodeficiency virus disease American Journal of Medicine. 101: 34-40. PMID 8686712 DOI: 10.1016/S0002-9343(96)00077-0  0.84
1996 Arnott MA, Hay J, Peutherer JF, Moore RD, Chaisson RE. Neutropenia and iatrogenic neutrophil dysfunction in human immunodeficiency virus infection and acquired immunodeficiency syndrome [2] Archives of Internal Medicine. 156: 1475-1476. PMID 8678719  0.84
1996 Moore RD, Keruly JC, Chaisson RE. Duration of the survival benefit of zidovudine therapy in HIV infection Archives of Internal Medicine. 156: 1073-1077. PMID 8638994 DOI: 10.1001/archinte.156.10.1073  0.84
1996 Ewig S, Gallani JE, Bartlett JG, Chaisson RE. The effect of prophylaxis on the outcome of HIV-associated Pneumocystis carinii pneumonia [7] Chest. 109: 586-587. PMID 8620753  0.84
1996 Moore RD, Chaisson RE. Natural history of opportunistic disease in an HIV-infected urban clinical cohort Annals of Internal Medicine. 124: 633-642. PMID 8607591  0.84
1996 Chaisson RE, Keruly JC, McAvinue S, Gallant JE, Moore RD. Effects of an incentive and education program on return rates for PPD test reading in patients with HIV infection Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 11: 455-459. PMID 8605590  0.84
1996 Gebo KA, Moore RD, Keruly JC, Chaisson RE. Risk factors for pneumococcal disease in human immunodeficiency virus-infected patients Journal of Infectious Diseases. 173: 857-862. PMID 8603963  0.84
1996 Maenza JR, Chaisson RE. HIV disease and its treatment: Current status and future prospects International Review of Psychiatry. 8: 167-175.  0.84
1996 Gallant JE, Abrams JE, McAvinue SM, Quinn TC, Chaisson RE. Previously unrecognized HIV infection among hospitalized patients Infectious Diseases in Clinical Practice. 5: 380-386.  0.84
1995 Chaisson RE. Mycobacterium avium complex and HIV Journal of the International Association of Physicians in Aids Care. 1: 10-15. PMID 11362745  0.84
1995 Moore RD, Chaisson RE. Survival analysis of two controlled trials of rifabutin prophylaxis against Mycobacterium avium complex in AIDS Aids. 9: 1337-1342. PMID 8605053  0.84
1995 Glesby MJ, Moore RD, Chaisson RE. Clinical Spectrum of Herpes Zoster in Adults Infected with Human Immunodeficiency Virus Clinical Infectious Diseases. 21: 370-375. PMID 8562746 DOI: 10.1093/clinids/21.2.370  0.84
1995 Chaisson RE. Mycobacterial infections and HIV Kekkaku. 70: 313-320. PMID 7760541  0.84
1995 Albrecht H, Stellbrink HJ, Gallant JE, Moore RD, Chaisson RE. Prophylaxis for opportunistic infections [3] Annals of Internal Medicine. 122: 730-731. PMID 7702240  0.84
1995 Chaulk CP, Moore-Rice K, Rizzo R, Chaisson RE. Eleven years of community-based directly observed therapy for tuberculosis Journal of the American Medical Association. 274: 945-951. PMID 7674524  0.84
1995 Fortgang IS, Peter AB, Belitsos PC, Chaisson RE, Moore RD. Hepatomegaly and steatosis in HIV-infected patients receiving nucleoside analog antiretroviral therapy American Journal of Gastroenterology. 90: 1433-1436. PMID 7661164  0.84
1995 Chaisson RE, Keruly JC, Moore RD. Race, sex, drug use, and progression of human immunodeficiency virus disease New England Journal of Medicine. 333: 751-756. PMID 7643881 DOI: 10.1056/NEJM199509213331202  0.84
1995 Moore RD, Keruly JC, Chaisson RE. Neutropenia and Bacterial Infection in Acquired Immunodeficiency Syndrome Archives of Internal Medicine. 155: 1965-1970. PMID 7575050 DOI: 10.1001/archinte.1995.00430180067008  0.84
1995 Chaisson RE. AIDS and mycobacterial infections Infections in Medicine. 12: 48-57.  0.84
1995 Barditch-Crovo P, Chaisson RE. Adverse reactions to therapy for HIV infection Emergency Medicine Clinics of North America. 13: 133-146.  0.84
1994 Small PM, Hopewell PC, Schecter GF, Chaisson RE, Goodman PC. Evolution of chest radiographs in treated patients with pulmonary tuberculosis and HIV infection Journal of Thoracic Imaging. 9: 74-77. PMID 8207783  0.84
1994 Gallant JE, Moore RD, Chaisson RE. Prophylaxis for opportunistic infections in patients with HIV infection Annals of Internal Medicine. 120: 932-944. PMID 8172439  0.84
1994 Moore RD, Hidalgo J, Bareta JC, Chaisson RE. Zidovudine therapy and health resource utilization in AIDS Journal of Acquired Immune Deficiency Syndromes. 7: 349-354. PMID 8133446  0.84
1994 Gallant JE, Moore RD, Richman DD, Keruly J, Chaisson RE. Risk factors for Kaposi's sarcoma in patients with advanced human immunodeficiency virus disease treated with zidovudine Archives of Internal Medicine. 154: 566-572. PMID 8122950 DOI: 10.1001/archinte.154.5.566  0.84
1994 Moore RD, Stanton D, Gopalan R, Chaisson RE. Racial differences in the use of drug therapy for HIV disease in an urban community. The New England Journal of Medicine. 330: 763-8. PMID 8107743 DOI: 10.1056/NEJM199403173301107  0.84
1994 Clark TE, Chaisson RE. Smoking cessation in patients with HIV Journal of the American Medical Association. 272: 564. PMID 8046815 DOI: 10.1001/jama.272.7.564  0.84
1994 Simon PA, Sorvillo FJ, Lapin RK, Moore RD, Chaisson RE. Racial differences in the use of drug therapy for HIV disease [4] New England Journal of Medicine. 331: 333-334. PMID 8022459 DOI: 10.1056/NEJM199408043310517  0.84
1994 Alwood K, Keruly J, Moore-Rice K, Stanton DL, Chaulk CP, Chaisson RE. Effectiveness of supervised, intermittent therapy for tuberculosis in HIV-infected patients Aids. 8: 1103-1108. PMID 7986406  0.84
1994 Moore RD, Chaisson RE, Hidalgo J. The Efficacy of Zidovudine Is Time Limited Jama: the Journal of the American Medical Association. 272: 1001. DOI: 10.1001/jama.1994.03520130035018  0.84
1994 Chaulk CP, Chaisson RE, Lewis JN, Rizzo RT. Treating Multidrug-Resistant Tuberculosis: Compliance and Side Effects Jama: the Journal of the American Medical Association. 271: 103-104. DOI: 10.1001/jama.1994.03510260027017  0.84
1994 Chaisson RE, Goedert JJ. Epidemiology of HIV infection among hemophiliacs and importance of CD4+ cells as surrogate markers Aids Patient Care. 8.  0.84
1994 Gallant JE, Alwood K, Chaisson RE. Osteomyelitis due to mycobacterium kansasii and mycobacterium avium complex in an HIV-infected patient Infectious Diseases in Clinical Practice. 3: 297-299.  0.84
1994 Eyster ME, Silva E, Lee C, Aledort LM, Mannucci PM, Chaisson RE. Impact of HIV and its treatment on chronic hepatitis C in hemophiliacs Aids Patient Care. 8.  0.84
1993 McDiarmid MA, Fujikawa J, Schaefer J, Weinmann G, Chaisson RE, Hudson CA. Health effects and exposure assessment of aerosolized pentamidine handlers Chest. 104: 382-385. PMID 8339622  0.84
1993 Gallant JE, Eldred LJ, Leslie JM, Chaisson RE, Quinn TC. Impact of the 1993 revision of the CDC case definition on the performance of the WHO and PAHO clinical case definitions for AIDS. Aids (London, England). 7: 1396-7. PMID 8267920  0.84
1993 Graham NMH, Chaisson RE. Tuberculosis and HIV infection: Epidemiology, pathogenesis, and clinical aspects Annals of Allergy. 71: 421-433. PMID 8250347  0.84
1993 Johnson MP, Chaisson RE. Tuberculosis and HIV disease Aids Clinical Review. 73-93. PMID 8217905  0.84
1993 Ward BJ, Humphrey JH, Clement L, Chaisson RE. Vitamin A status in HIV infection Nutrition Research. 13: 157-166. DOI: 10.1016/S0271-5317(05)80437-3  0.84
1992 Samuels JF, Vlahov D, Anthony JC, Chaisson RE. Measurement of HIV risk behaviors among intravenous drug users. British Journal of Addiction. 87: 417-28. PMID 1559040 DOI: 10.1111/j.1360-0443.1992.tb01942.x  0.84
1992 Moore RD, Keruly J, Richman DD, Creagh-Kirk T, Chaisson RE. Natural history of advanced HIV disease in patients treated with zidovudine Aids. 6: 671-677. PMID 1503686  0.84
1992 Nordback IH, Olson JL, Chaisson RE, Cameron JL. Acute effects of a nucleoside analog dideoxyinosine (DDI) on the pancreas Journal of Surgical Research. 53: 610-614. PMID 1494295 DOI: 10.1016/0022-4804(92)90262-X  0.84
1992 McDiarmid MA, Schaefer J, Richard CL, Chaisson RE, Tepper BS. Efficacy of engineering controls in reducing occupational exposure to aerosolized pentamidine Chest. 102: 1764-1766. PMID 1446486  0.84
1992 Gallant JE, Mueller PS, McArthur JC, Chaisson RE. Intramedullary tuberculoma in a patient with HIV infection [10] Aids. 6: 889-891. PMID 1418794  0.84
1992 Chaisson RE, Keruly J, Richman DD, Moore RD. Pneumocystis Prophylaxis and Survival in Patients With Advanced Human Immunodeficiency Virus Infection Treated With Zidovudine Archives of Internal Medicine. 152: 2009-2013. PMID 1417373 DOI: 10.1001/archinte.1992.00400220041007  0.84
1992 Gallant JE, Somani J, Chaisson RE, Stanton D, Smith M, Quinn TC. Diagnostic accuracy of three clinical case definitions for advanced HIV disease. Aids (London, England). 6: 295-9. PMID 1348946  0.84
1992 Chaisson RE, Taylor E, Margolick JB, Munoz A, Solomon L, Cohn S, Nelson KE, Vlahov D. Immune serum markers and cd4 cell counts in hiv-infected intravenous drug users Journal of Acquired Immune Deficiency Syndromes. 5: 456-460. PMID 1348535  0.84
1991 Chaisson RE, McAvinue S. Control of tuberculosis during aerosol therapy administration Respiratory Care. 36: 1017-1025. PMID 10145536  0.84
1991 Moore RD, Hidalgo J, Sugland BW, Chaisson RE. Zidovudine and the natural history of the acquired immunodeficiency syndrome New England Journal of Medicine. 324: 1412-1416. PMID 2020297  0.84
1991 Moore RD, Kessler H, Richman DD, Flexner C, Chaisson RE. Non-Hodgkin’s Lymphoma in Patients With Advanced HIV Infection Treated With Zidovudine Jama: the Journal of the American Medical Association. 265: 2208-2211. PMID 2013953 DOI: 10.1001/jama.1991.03460170062034  0.84
1991 Barbacci M, Repke JT, Chaisson RE. HIV testing urged for pregnancy Nursing Times. 87: 11. PMID 2011546  0.84
1991 Valainis GT, Chaisson RE, Levine B. Mycobacterium kansasii infection [1] Annals of Internal Medicine. 115: 496-497. PMID 1872499  0.84
1991 Levine B, Chaisson RE. Mycobacterium kansasii: A cause of treatable pulmonary disease associated with advanced human immunodeficiency virus (HIV) infection Annals of Internal Medicine. 114: 861-868. PMID 1673053  0.84
1991 Barbacci M, Chaisson RE, Repke JT. Routine prenatal screening for HIV infection The Lancet. 337: 709-711. PMID 1672184 DOI: 10.1016/0140-6736(91)90286-X  0.84
1991 Chaisson RE, Griffin DE. Clinical case report: Progressive multifocal leukoencephalopathy in AIDS Aids Patient Care. 5: 223-226.  0.84
1990 Chaisson RE. Prevention of opportunistic infections in patients with HIV Maryland Medical Journal. 39: 156-160. PMID 2406531  0.84
1990 Chaisson RE, Griffin DE. Progressive Multifocal Leukoencephalopathy in AIDS Jama: the Journal of the American Medical Association. 264: 79-82. PMID 2355432 DOI: 10.1001/jama.1990.03450010083036  0.84
1990 Chaisson RE. Living With AIDS Jama: the Journal of the American Medical Association. 263: 434-436. PMID 2294309 DOI: 10.1001/jama.1990.03440030121034  0.84
1990 Chaisson RE, Smith MD. Pneumocystis carinii pneumonia: Diagnosis and management Maryland Medical Journal. 39: 365-369. PMID 2185391  0.84
1990 Chaisson RE, Hopewell PC. Survival after active tuberculosis in patients with HIV infection (I: Reply) American Review of Respiratory Disease. 142: 259.  0.84
1989 Chaisson RE, Hopewell PC. Mycobacteria and AIDS mortality American Review of Respiratory Disease. 139: 1-3. PMID 2912328  0.84
1989 Chaisson RE, Bacchetti P, Osmond D, Brodie B, Sande MA, Moss AR. Cocaine Use and HIV Infection in Intravenous Drug Users in San Francisco Jama: the Journal of the American Medical Association. 261: 561-565. PMID 2909798 DOI: 10.1001/jama.1989.03420040099027  0.84
1989 Chaisson RE. Tuberculosis and HIV infection - New opportunities for an old pathogen Western Journal of Medicine. 150: 687-689. PMID 2750153  0.84
1989 Chaisson RE, Slutkin G. Tuberculosis and Human Immunodeficiency Virus Infection Journal of Infectious Diseases. 159: 96-100. PMID 2642524 DOI: 10.1093/infdis/159.1.96  0.84
1989 Chaisson RE. Bacterial pneumonia in patients with human immunodeficiency virus infection Seminars in Respiratory Infections. 4: 133-138. PMID 2501846  0.84
1988 Rosenthal PJ, Chaisson RE, Hadley WK, Leech JH. Rectal leishmaniasis in a patient with acquired immunodeficiency syndrome The American Journal of Medicine. 84: 307-309. PMID 3407656 DOI: 10.1016/0002-9343(88)90430-5  0.84
1988 Chaisson RE. Infections due to encapsulated bacteria, Salmonella, Shigella, and Campylobacter Infectious Disease Clinics of North America. 2: 475-484. PMID 3060531  0.84
1988 Chaisson RE, Hopewell PC. In Reply Jama: the Journal of the American Medical Association. 259: 2850. DOI: 10.1001/jama.1988.03720190021020  0.84
1987 Celum CL, Chaisson RE, Rutherford GW, Barnhart JL, Echenberg DE. Incidence of salmonellosis in patients with aids Journal of Infectious Diseases. 156: 998-1002. PMID 3680999 DOI: 10.1093/infdis/156.6.998  0.84
1987 Leoung GS, Chaisson RE, Mills J. Comparison of nosocomial infections due to Staphylococcus aureus and enterococci in a general hospital Surgery Gynecology and Obstetrics. 165: 339-342. PMID 3660197  0.84
1987 Chaisson RE, Hopewell PC. Empiric Diagnosis of Pneumocystis Pneumonia Jama: the Journal of the American Medical Association. 258: 3385. PMID 3500330 DOI: 10.1001/jama.1987.03400230045016  0.84
1987 Chaisson RE, Moss AR, Onishi R, Osmond D, Carlson JR. Human immunodeficiency virus infection in heterosexual intravenous drug users in San Francisco American Journal of Public Health. 77: 169-172. PMID 3467596  0.84
1986 Chaisson RE, Ross J, Gerberding JL, Sande MA. Clinical aspects of adult epiglottitis Western Journal of Medicine. 144: 700-703. PMID 3524004  0.84
1986 Chaisson RE, Allain JP, Leuther M, Volberding PA. Significant changes in HIV antigen level in the serum of patients treated with azidothymidine New England Journal of Medicine. 315: 1610-1611. PMID 3466034  0.84
Show low-probability matches.